Clinical Trial Update: Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin for gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Epirubicin (epirubicin)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED